Doug Hampton

Medical Device Manufacturing Outsourcing Market size to grow by USD 46,241.15 million from 2022 to 2027; Growing focus of OEMs on reducing medical device manufacturing costs

by

NEW YORK, May 12, 2023 /PRNewswire/ — The medical device manufacturing outsourcing market is set to grow by USD 46241.15 million from 2022 to 2027 progressing at a CAGR of 10.85% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is … Read more

Global Pharma, Biotech and Diagnostics Distribution Partnering Analysis Report 2023 with a Directory of 2,200 Deals

by

DUBLIN, May 12, 2023 /PRNewswire/ — The “Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 to 2023” report has been added to ResearchAndMarkets.com’s offering. The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 report provides comprehensive access to available records for over 2,200 distribution deals, including contract documents … Read more

Syntec Optics, a Leading Optics and Photonics Company, to Publicly List on Nasdaq through Business Combination with OmniLit Acquisition Corp.

by

ROCHESTER, N.Y., May 12, 2023 /PRNewswire/ — Syntec Optics, Inc. (“Syntec Optics”) has entered into a definitive business combination agreement with OmniLit Acquisition Corp. (Nasdaq: OLIT), (or “OmniLit”); upon or following closing, OmniLit will be renamed Syntec Optics Holdings, Inc. and listed on Nasdaq under the new ticker OPTX.  The board of directors and the … Read more

TEXAS CHILDREN’S HOSPITAL’S DR. PETER HOTEZ AND DR. MARIA ELENA BOTTAZZI RECEIVE THE 2023 LYNDON B. JOHNSON MORAL COURAGE AWARD

by

The internationally recognized infectious disease experts were honored for their pioneering research to develop a safe, affordable COVID-19 vaccine technology to benefit the world HOUSTON, May 12, 2023 /PRNewswire/ — Texas Children’s Hospital is pleased to announce that Dr. Peter Hotez, Co-Director of the Texas Children’s Hospital Center for Vaccine Development and Dean of the … Read more

Healthcare Workers at Five HCA Hospitals Vote to Strike Over Management’s Threats, Initimidation, Other Unfair Labor Practices

by

Vote margin was 97 percent in favor of a strike and applies to approximately 3,000 healthcare workers across California RIVERSIDE, Calif. and SAN JOSE, Calif., May 12, 2023 /PRNewswire/ — Thousands of healthcare workers at five HCA facilities in California have voted to authorize an unfair labor practice strike to demand their employer stop the … Read more

Boppy Demands Action from Facebook, Stop the Resale of Recalled Products like Newborn Lounger

by

GOLDEN, Colo., May 12, 2023 /PRNewswire/ – The Boppy Company is publicly calling on Facebook to remove from its Marketplace platform all listings of the company’s recalled Newborn Lounger. Despite a voluntary recall and direct communication from The Boppy Company, and in violation of the law, Meta continues to allow recalled Newborn Loungers to be … Read more

MRI coils market to grow by USD 1,385.59 million between 2022 and 2027; Growth driven by increasing number of MRI procedures

by

NEW YORK, May 12, 2023 /PRNewswire/ — The MRI coils market size is set to grow by USD 1,385.59 million between 2022 and 2027 and register a CAGR of 5.84%, according to Technavio’s latest market research report estimates. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by way of … Read more

PACU Foundation’s Flying Colors Charity Fun Run draws support and fun for a good cause

by

WINSTON-SALEM, N.C., May 12, 2023 /PRNewswire/ — The PACU Foundation’s inaugural Flying Colors Charity Fun Run raised more than $4,000 from 15 generous corporate sponsors and individual donors and 57 runners and walkers of all ages across the Triad region of North Carolina. The event was held on Saturday, May 6, at the Oak Ridge … Read more

Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments

by

Acquired exclusive license for oral, brain-penetrant, dual TYK2/JAK1 inhibitor for immune-mediated brain disorders in March 2023 covering global rights (excluding China) Appointed Nick Kozauer, M.D. as SVP of Clinical Development and Regulatory Strategy following his tenure as Director of the Division of Neurology 2 in the Office of New Drugs of the U.S. Food and … Read more

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2023 Financial Results and Provides Business Update

by

$29.1 million in cash and cash equivalents as of March 31, 2023; $15 million registered direct offering in May 2023 extends runway through May 2024 Halo-Lido Phase 2b trial completed with topline results anticipated by end of calendar Q2 2023 CRANFORD, N.J., May 12, 2023 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: … Read more